Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis
ADR ID BADD_A02019
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.004      Hepatitis
Description INFLAMMATION of the LIVER. [MeSH]
MedDRA Code 10019717
MeSH ID D006505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatitis | Hepatitis in other infectious diseases classified elsewhere | Hepatitis nonicteric | Hepatitis nonspecific | Hepatitis NOS | Hepatitis reactive non-specific | Hepatitis symptom | Hepatitis, unspecified | Nonspecific hepatitis | Hepatitis aggravated | Hepatitis non-icteric | Syncytial giant cell hepatitis | Hepatitis flare | Liver inflammation | Icteric hepatitis | Hepatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01453Mexiletine hydrochloride--
BADD_D01454Mianserin--
BADD_D01455Micafungin0.000150%
BADD_D01457Miconazole--
BADD_D01466Milnacipran hydrochloride--
BADD_D01470Minocycline0.002149%
BADD_D01471Minocycline anion--
BADD_D01472Minocycline hydrochloride--
BADD_D01476Mirtazapine0.000520%
BADD_D01479Mitotane--
BADD_D01480Mitoxantrone--
BADD_D01485Moexipril hydrochloride--
BADD_D01486Moexiprilat--
BADD_D01496Montelukast--
BADD_D01498Morphine--
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01506Muromonab-cd3--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.000951%
BADD_D01522Nalmefene--
BADD_D01527Naltrexone--
BADD_D01528Naltrexone hydrochloride--
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine--
BADD_D01558Nexium--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 21 Pages
ADReCS-Target
ADR Term Drug Name Target